Strategies to Improve Efficacy and Safety of a Novel Class of Antiviral Hyper-Activation-Limiting Therapeutic Agents: The VS411 Model HIV/AIDS

British Journal of Pharmacology - United States
doi 10.1111/j.1476-5381.2010.00940.x
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

VS411 Reduced Immune Activation and HIV-1 RNA Levels in 28 Days: Randomized Proof-Of-Concept Study for AntiViral-HyperActivation Limiting Therapeutics

PLoS ONE
Multidisciplinary
2012English

ABC of AIDS: Treatment of Infections and Antiviral Agents

BMJ
1987English

Should Evidence-Based Proof of Efficacy as Defined for a Specific Therapeutic Agent Be Extrapolated to Encompass a Therapeutic Class of Agents?

Circulation
Cardiovascular MedicinePhysiologyCardiology
2003English

The Efficacy of Testing and Counseling in Limiting HIV Transmission.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1994English

Structure of Human dCK Suggests Strategies to Improve Anticancer and Antiviral Therapy

Nature Structural and Molecular Biology
Structural BiologyMolecular Biology
2003English

A Class Age-Structured HIV/AIDS Model With Impulsive Drug-Treatment Strategy

Discrete Dynamics in Nature and Society
ModelingSimulation
2010English

Anti-Aids Agents 69. Moronic Acid and Other Triterpene Derivatives as Novel Potent Anti-Hiv Agents

English

Therapeutic Strategies to Enhance the Anticancer Efficacy of Histone Deacetylase Inhibitors

Journal of Biomedicine and Biotechnology
2011English

Processing and Storage of Blood Components: Strategies to Improve Patient Safety

International Journal of Clinical Transfusion Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy